Binding of eEF1A2 to the RNA-dependent protein kinase PKR modulates its activity and promotes tumour cell survival
Alejandro Losada(PharmaMar (Spain)), Carlos M. Galmarini(Artificial Intelligence Research Institute)
Cited by 39
Related Papers
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
|Science|2021|364
Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin
|Scientific Reports|2016|95
Synergistic Effect of Trabectedin and Olaparib Combination Regimen in Breast Cancer Cell Lines
|Journal of Breast Cancer|2015|28
Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™
|British Journal of Cancer|2004|26
Plitidepsin as an Immunomodulator against Respiratory Viral Infections
|The Journal of Immunology|2024|6